The two main manufacturers for GLP-1s, Novo and Lilly, both provide DTC options that can make the meds more affordable to patients who can't use their insurance for them
[1] [2] In the pancreas (-cells of the islets of Langerhans), proglucagon is cleaved by prohormone convertase (PC) 2 producing glicentin-related pancreatic peptide (GRPP), glucagon, intervening peptide-1 (IP-1) and major proglucagon fragment (MPGF)
Both can influence gut health, but through different mechanisms
Their clinic offering brings that decades-long behavioral science expertise into the GLP-1 er
However, Mochi's clinical depth depends on the provider's assessment during a typically brief video call, which may not include specialized metabolic testing or genetic considerations relevant to GLP-1 response variability
Subsequently, it was shown that hamster and human preproglucagon cDNAs encode GLP-1 and 2, but only GLP-1 possessed incretin